February 25, 2016 – The European Medicines Agency (EMA) warns of at least 100 cases of diabetic ketoacidosis in patients treated with SGLT2 inhibitors.
February 25, 2016 – The European Medicines Agency (EMA) warns of at least 100 cases of diabetic ketoacidosis in patients treated with SGLT2 inhibitors.